A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants

Clinical trial NCT06294288 · COMPLETED

Trial details

NCT number: NCT06294288
Sponsor: Longbio Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Spontaneous Urticaria

Start date: 2022-07-13
Primary completion: 2024-03-04
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.